ProfileGDS4132 / 235725_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 85% 77% 80% 81% 86% 86% 85% 86% 83% 82% 85% 88% 87% 87% 81% 85% 78% 88% 84% 82% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101313.44585
GSM201543Muscle PCOS pioglitazone 121238.88477
GSM201544Muscle PCOS pioglitazone 161288.46780
GSM201545Muscle PCOS pioglitazone 201307.94381
GSM201829Muscle PCOS pioglitazone 231348.43386
GSM201830Muscle PCOS pioglitazon 251340.02986
GSM201831Muscle PCOS pioglitazone 271334.41685
GSM201832Muscle PCOS pioglitazone 31341.81386
GSM201833Muscle PCOS pioglitazone 41297.52983
GSM201834Muscle PCOS pioglitazone 81307.08182
GSM201835Muscle PCOS after pioglitazone 102337.96485
GSM201836Muscle PCOS after pioglitazone 122407.38988
GSM201837Muscle PCOS after pioglitazone 162363.9187
GSM201838Muscle PCOS after pioglitazone 202407.25687
GSM201839Muscle PCOS after pioglitazone 232299.3881
GSM201840Muscle PCOS after pioglitazone 252360.68585
GSM201841Muscle PCOS after pioglitazone 272253.51978
GSM201842Muscle PCOS after pioglitazone 32367.81288
GSM201843Muscle PCOS after pioglitazone 42317.98984
GSM201844Muscle PCOS after pioglitazone 82315.40382